Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles

Several COVID-19 vaccine strategies utilizing new formulations for the induction of neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical and clinical studies. Here we used Simian Immunodeficiency Virus (SIV)-based integrase defective lentiviral vector (IDLV) d...

Full description

Bibliographic Details
Main Authors: Martina Borghi, Alessandra Gallinaro, Maria Franca Pirillo, Andrea Canitano, Zuleika Michelini, Maria Laura De Angelis, Serena Cecchetti, Antonella Tinari, Chiara Falce, Sabrina Mariotti, Antonio Capocefalo, Maria Vincenza Chiantore, Angelo Iacobino, Antonio Di Virgilio, Marit J. van Gils, Rogier W. Sanders, Alessandra Lo Presti, Roberto Nisini, Donatella Negri, Andrea Cara
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1147953/full
_version_ 1797852216092000256
author Martina Borghi
Alessandra Gallinaro
Maria Franca Pirillo
Andrea Canitano
Zuleika Michelini
Maria Laura De Angelis
Serena Cecchetti
Antonella Tinari
Chiara Falce
Sabrina Mariotti
Antonio Capocefalo
Maria Vincenza Chiantore
Angelo Iacobino
Antonio Di Virgilio
Marit J. van Gils
Rogier W. Sanders
Alessandra Lo Presti
Roberto Nisini
Donatella Negri
Andrea Cara
author_facet Martina Borghi
Alessandra Gallinaro
Maria Franca Pirillo
Andrea Canitano
Zuleika Michelini
Maria Laura De Angelis
Serena Cecchetti
Antonella Tinari
Chiara Falce
Sabrina Mariotti
Antonio Capocefalo
Maria Vincenza Chiantore
Angelo Iacobino
Antonio Di Virgilio
Marit J. van Gils
Rogier W. Sanders
Alessandra Lo Presti
Roberto Nisini
Donatella Negri
Andrea Cara
author_sort Martina Borghi
collection DOAJ
description Several COVID-19 vaccine strategies utilizing new formulations for the induction of neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical and clinical studies. Here we used Simian Immunodeficiency Virus (SIV)-based integrase defective lentiviral vector (IDLV) delivering different conformations of membrane-tethered Spike protein in the mouse immunogenicity model, with the aim of inducing persistent nAbs against multiple SARS-CoV-2 variants of concern (VoC). Spike modifications included prefusion-stabilizing double proline (2P) substitutions, mutations at the furin cleavage site (FCS), D614G mutation and truncation of the cytoplasmic tail (delta21) of ancestral and Beta (B.1.351) Spike, the latter mutation to markedly improve IDLV membrane-tethering. BALB/c mice were injected once with IDLV delivering the different forms of Spike or the recombinant trimeric Spike protein with 2P substitutions and FCS mutations in association with a squalene-based adjuvant. Anti-receptor binding domain (RBD) binding Abs, nAbs and T cell responses were detected up to six months from a single immunization with escalating doses of vaccines in all mice, but with different levels and kinetics. Results indicated that IDLV delivering the Spike protein with all the combined modifications, outperformed the other candidates in terms of T cell immunity and level of both binding Abs and nAbs soon after the single immunization and persistence over time, showing the best capacity to neutralize all formerly circulating VoC Alpha, Beta, Gamma and Delta. Although present, the lowest response was detected against Omicron variants (BA.1, BA.2 and BA.4/5), suggesting that the magnitude of immune evasion may be related to the higher genetic distance of Omicron as indicated by increased number of amino acid substitutions in Spike acquired during virus evolution.
first_indexed 2024-04-09T19:30:24Z
format Article
id doaj.art-d6a90457e0554050aaece8683c609075
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T19:30:24Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-d6a90457e0554050aaece8683c6090752023-04-05T04:25:47ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-04-011410.3389/fimmu.2023.11479531147953Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profilesMartina Borghi0Alessandra Gallinaro1Maria Franca Pirillo2Andrea Canitano3Zuleika Michelini4Maria Laura De Angelis5Serena Cecchetti6Antonella Tinari7Chiara Falce8Sabrina Mariotti9Antonio Capocefalo10Maria Vincenza Chiantore11Angelo Iacobino12Antonio Di Virgilio13Marit J. van Gils14Rogier W. Sanders15Alessandra Lo Presti16Roberto Nisini17Donatella Negri18Andrea Cara19Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Rome, ItalyDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, ItalyConfocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, ItalyCenter for Gender Medicine, Istituto Superiore di Sanità, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Rome, ItalyDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyDepartment of Veterinary Public Health & Food Safety, Istituto Superiore di Sanità, Rome, ItalyDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyCenter for Animal Research and Welfare, Istituto Superiore di Sanità, Rome, ItalyDepartment of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, NetherlandsDepartment of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, NetherlandsDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, ItalyNational Center for Global Health, Istituto Superiore di Sanità, Rome, ItalySeveral COVID-19 vaccine strategies utilizing new formulations for the induction of neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical and clinical studies. Here we used Simian Immunodeficiency Virus (SIV)-based integrase defective lentiviral vector (IDLV) delivering different conformations of membrane-tethered Spike protein in the mouse immunogenicity model, with the aim of inducing persistent nAbs against multiple SARS-CoV-2 variants of concern (VoC). Spike modifications included prefusion-stabilizing double proline (2P) substitutions, mutations at the furin cleavage site (FCS), D614G mutation and truncation of the cytoplasmic tail (delta21) of ancestral and Beta (B.1.351) Spike, the latter mutation to markedly improve IDLV membrane-tethering. BALB/c mice were injected once with IDLV delivering the different forms of Spike or the recombinant trimeric Spike protein with 2P substitutions and FCS mutations in association with a squalene-based adjuvant. Anti-receptor binding domain (RBD) binding Abs, nAbs and T cell responses were detected up to six months from a single immunization with escalating doses of vaccines in all mice, but with different levels and kinetics. Results indicated that IDLV delivering the Spike protein with all the combined modifications, outperformed the other candidates in terms of T cell immunity and level of both binding Abs and nAbs soon after the single immunization and persistence over time, showing the best capacity to neutralize all formerly circulating VoC Alpha, Beta, Gamma and Delta. Although present, the lowest response was detected against Omicron variants (BA.1, BA.2 and BA.4/5), suggesting that the magnitude of immune evasion may be related to the higher genetic distance of Omicron as indicated by increased number of amino acid substitutions in Spike acquired during virus evolution.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1147953/fulllentiviral vector (LV)IDLVvaccineSARS-CoV-2neutralizing Abs
spellingShingle Martina Borghi
Alessandra Gallinaro
Maria Franca Pirillo
Andrea Canitano
Zuleika Michelini
Maria Laura De Angelis
Serena Cecchetti
Antonella Tinari
Chiara Falce
Sabrina Mariotti
Antonio Capocefalo
Maria Vincenza Chiantore
Angelo Iacobino
Antonio Di Virgilio
Marit J. van Gils
Rogier W. Sanders
Alessandra Lo Presti
Roberto Nisini
Donatella Negri
Andrea Cara
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
Frontiers in Immunology
lentiviral vector (LV)
IDLV
vaccine
SARS-CoV-2
neutralizing Abs
title Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
title_full Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
title_fullStr Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
title_full_unstemmed Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
title_short Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
title_sort different configurations of sars cov 2 spike protein delivered by integrase defective lentiviral vectors induce persistent functional immune responses characterized by distinct immunogenicity profiles
topic lentiviral vector (LV)
IDLV
vaccine
SARS-CoV-2
neutralizing Abs
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1147953/full
work_keys_str_mv AT martinaborghi differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT alessandragallinaro differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT mariafrancapirillo differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT andreacanitano differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT zuleikamichelini differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT marialauradeangelis differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT serenacecchetti differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT antonellatinari differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT chiarafalce differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT sabrinamariotti differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT antoniocapocefalo differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT mariavincenzachiantore differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT angeloiacobino differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT antoniodivirgilio differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT maritjvangils differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT rogierwsanders differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT alessandralopresti differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT robertonisini differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT donatellanegri differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles
AT andreacara differentconfigurationsofsarscov2spikeproteindeliveredbyintegrasedefectivelentiviralvectorsinducepersistentfunctionalimmuneresponsescharacterizedbydistinctimmunogenicityprofiles